Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-20

Clinical Trial Update: Cyproheptadine and Chlorpromazine Effects on Spasticity

View source ↗

Summary

A completed University of Alberta trial investigated the effects of cyproheptadine and chlorpromazine on spasticity in individuals with spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorpromazine (chlorpromazine)
  • Cyproheptadine (cyproheptadine)

Snippet

Sponsor: University of Alberta | Conditions: Spinal Cord Injuries, Muscle Spasticity | Status: COMPLETED